AI News about therapeutics
Latest news and AI summaries about therapeutics · 2 articles
About therapeutics
Latest AI-curated news and analysis about therapeutics, including breaking stories, expert analysis, and global coverage. Updated in real-time with AI-powered summaries to keep you informed.
Related: eli lilly · centessa pharmaceuticals · sleep-wake disorders · neuroscience · pharmaceutical acquisition
Trending Topics
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Lilly Acquires Centessa to Expand Sleep Disorder Pipeline Eli Lilly is acquiring Centessa Pharmaceuticals in a strategic move to advance its portfolio of sleep-wake disorder treatments. The clinical-stage company brings novel therapeutics that complement Lilly's existing neuroscience pipeline. This acquisition strengthens Lilly's position in the growing sleep medicine market.
PR Newswire: press release distribution, targeting, monitoring and marketing · 2026.04.01
Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights
Protagonist Lands FDA Win, Threatens Immunology Giants Protagonist Therapeutics received its first FDA approval, securing a $50 million immediate payment from its Johnson & Johnson partnership. The breakthrough positions the biotech company to challenge established players in the immunology sector. Industry analysts suggest the approval could reshape competitive dynamics among major pharmaceutical immunology programs.
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace · 2026.03.19